Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Abstracts of the 16th International Charles Heidelberger Symposium on Cancer Research

Open Access Open Badges Poster presentation

Relation between autophagy and the resistence of glioblastoma cells to temozolomide

Anália Carmo1*, Helena Carvalheiro1 and Maria C Lopes12

Author Affiliations

1 Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal

2 Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal

For all author emails, please log on.

BMC Proceedings 2010, 4(Suppl 2):P20  doi:10.1186/1753-6561-4-S2-P20

The electronic version of this article is the complete one and can be found online at:

Published:24 September 2010

© 2010 Carmo et al; licensee BioMed Central Ltd.

Poster presentation

Gliomas are brain tumours that account for more than 50% of the tumours that arise within the central nervous system. They are highly proliferative, angiogenic, and develop resistance to the alkylating agents used in chemotherapy. The median survival time for glioma patients remains approximately 12-14 months in patients treated with temozolomide (TMZ) which is considered the main chemotherapeutic agent. In order to understand the cellular mechanisms involved in chemoresistance of glioma cells we analysed the activation of autophagy in cells treated with TMZ. In addition, we determined the effect of TMZ in the survival pathways PI3K/Akt and MAP kinases. For that, U-118 glioma cells were incubated with different concentrations of TMZ for different periods of time. Activation of autophagy and of PI3K/Akt and MAP kinase was evaluated by western blot. Apoptosis was addressed by confocal microscopy and by flow cytometry. The results indicated that in glioma cells treated with TMZ there was an increased expression of LC3 indicated that TMZ activated autophagy. Glioma cells presented a basal activation of PI3K/Akt and MAP kinases which was not blocked by TMZ. TMZ was also unable to induce apoptosis in a significant percentage of cells. Together, these results suggested that chemoresistance of glioma cells to TMZ is due to TMZ inability to block the activation of the survival pathways of autophagy, PI3K/Akt and MAP kinases.


  1. Ziegler DS, Kung AL, Kieran MW: Anti-apoptosis mechanisms in malignant gliomas.

    J Clin Oncol 2008, 20:493-500. Publisher Full Text OpenURL

  2. Thorburn A: Apoptosis and autophagy: regulatory connections between two supposedly different processes.

    Apoptosis 2008, 13:1-9. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL